MIP Discovery is a technology leader in the field of Molecularly Imprinted Polymers (synthetic antibodies). The business has developed a novel, proprietary design and development process to make nanoMIPs; nano scale molecularly imprinted polymers, each with a high affinity, high specificity binding site. They are very robust in extreme temperatures and varying pH, enabling new applications where antibodies have reached their limits.

- Target biomarkers where antibodies have previously failed
- Create diagnostic devices that can withstand extreme conditions
- Achieve continuous supply security with an animal free, chemically produced product
- Deliver improved performance in POC devices

nanoMIPs are suitable for use in diagnostic assays, interference removal, biosensors and other applications in healthcare, IVD, environmental monitoring, security, agriculture, oil and gas and the food and beverage industry.

MIP Discovery offers a custom MIP development service and is growing a portfolio of off-the shelf nanoMIPs, including a high sensitivity COVID-19 nanoMIP.